Your browser doesn't support javascript.
loading
Evaluation of cumulative dose distributions from external beam radiation therapy using CT-to-CBCT deformable image registration (DIR) for cervical cancer patients.
Eckrich, Carolyn; Lee, Brandon; Wang, Chunhao; Light, Kim; Chino, Junzo; Rodrigues, Anna; Craciunescu, Oana.
Afiliação
  • Eckrich C; Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, USA.
  • Lee B; MIM Software, Cleveland, Ohio, USA.
  • Wang C; Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, USA.
  • Light K; Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, USA.
  • Chino J; Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, USA.
  • Rodrigues A; Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, USA.
  • Craciunescu O; Duke University Medical Center, Department of Radiation Oncology, Durham, North Carolina, USA.
J Appl Clin Med Phys ; : e14538, 2024 Oct 04.
Article em En | MEDLINE | ID: mdl-39365744
ABSTRACT

PURPOSE:

To investigate dose differences between the planning CT (pCT) and dose calculated on pre-treatment verification CBCTs using DIR and dose summation for cervical cancer patients.

METHODS:

Cervical cancer patients treated at our institution with 45 Gy EBRT undergo a pCT and 5 CBCTs, once every five fractions of treatment. A free-form intensity-based DIR in MIM was performed between the pCT and each CBCT using the "Merged CBCT" feature to generate an extended FOV-CBCT (mCBCT). DIR-generated bladder and rectum contours were adjusted by a physician, and dice similarity coefficients (DSC) were calculated. After deformation, the investigated doses were (1) recalculated in Eclipse using original plan parameters (ecD), and (2) deformed from planning dose (pD) using the deformation matrix in MIM (mdD). Dose summation was performed to the first week's mCBCT. Dose distributions were compared for the bladder, rectum, and PTV in terms of percent dose difference, dose volume histograms (DVHs), and gamma analysis between the calculated doses.

RESULTS:

For the 20 patients, the mean DSC was 0.68 ± 0.17 for bladder and 0.79 ± 0.09 for rectum. Most patients were within 5% of pD for D2cc (19/20), Dmax (17/20), and Dmean (16/20). All patients demonstrated a percent difference > 5% for bladder V45 due to variations in bladder volume from the pCT. D90 showed fewer differences with 19/20 patients within 2% of pD. Gamma rates between pD and ecD averaged 94% for bladder and 94% for rectum, while pD and mdD exhibited slightly better performance for bladder (93%) and lower for rectum (85%).

CONCLUSION:

Using DIR with weekly CBCT images, the MIM deformed dose (mdD) was found to be in close agreement with the Eclipse calculated dose (ecD). The proposed workflow should be used on a case-by-case basis when the weekly CBCT shows marked difference in organs-at-risk from the planning CT.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article